Hepatic-vein thrombosis after chemotherapy for histiocytoma.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D006502:Budd-Chiari Syndrome / Q000139:chemically induced*; D003520:Cyclophosphamide / Q000009:adverse effects; D003606:Dacarbazine / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D004359:Drug Therapy, Combination; D018219:Histiocytoma, Benign Fibrous / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy*; D014750:Vincristine / Q000009:adverse effects
D000970:Antineoplastic Agents; D014750:Vincristine; D003606:Dacarbazine; D004317:Doxorubicin; D003520:Cyclophosphamide